Speaker illustration

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation e-posters

Thumbnail

Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Rate Control

Session: Atrial fibrillation e-posters

Thumbnail

Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Stroke in Atrial Fibrillation

Session: Atrial fibrillation e-posters

Thumbnail

Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety

Event: EHRA 2021

Topic: Rhythm Control, Catheter Ablation

Session: Towards improved outcome of atrial ablation II

Thumbnail

Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS

Event: EHRA 2021

Topic: Stroke in Atrial Fibrillation

Session: Epidemiology and prognosis of atrial fibrillation

Thumbnail

Number needed to treat for net effect of anticoagulation in atrial fibrillation

Event: EHRA 2021

Topic: Oral Anticoagulation

Session: ePoster session

Thumbnail

This platform is supported by

logo Novo Nordisk